Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Suspended Phase 1 Trials for Fludarabine (DB01073)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0115568 (Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm) | Suspended | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT03326921 | HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant | Treatment |